Total Payments
$2,155
2024 Payments
$145.41
Companies
18
Transactions
44
Medicare Patients
2,245
Medicare Billing
$221,523
Payment Breakdown by Category
Food & Beverage$1,702 (79.0%)
Travel$303.03 (14.1%)
Other$150.00 (7.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,702 | 42 | 79.0% |
| Travel and Lodging | $303.03 | 1 | 14.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 1 | 7.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $461.51 | 3 | $0 (2019) |
| Gilead Sciences, Inc. | $338.47 | 3 | $0 (2021) |
| PFIZER INC. | $329.20 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $240.54 | 5 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $197.50 | 4 | $0 (2018) |
| Intercept Pharmaceuticals, Inc. | $121.14 | 1 | $0 (2018) |
| GENZYME CORPORATION | $111.97 | 1 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $65.10 | 4 | $0 (2022) |
| Olympus America Inc. | $46.88 | 2 | $0 (2018) |
| Braintree Laboratories, Inc. | $45.85 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.41 | 8 | PFIZER INC. ($32.02) |
| 2023 | $237.34 | 7 | GENZYME CORPORATION ($111.97) |
| 2022 | $191.03 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($150.00) |
| 2021 | $154.46 | 5 | Gilead Sciences, Inc. ($88.48) |
| 2019 | $954.20 | 7 | Boston Scientific Corporation ($461.51) |
| 2018 | $434.97 | 11 | Synergy Pharmaceuticals Inc ($197.50) |
| 2017 | $37.18 | 3 | PFIZER INC. ($24.69) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: GI COLON PREP | ||||||
| 08/22/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: GI COLON PREP | ||||||
| 08/14/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 06/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/22/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/31/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Immunology | ||||||
| 01/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/08/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Immunology | ||||||
| 12/02/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/16/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/15/2023 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/23/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $111.97 | General |
| Category: Immunology | ||||||
| 07/20/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: GI COLON PREP | ||||||
| 06/01/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Gastroenterology | ||||||
| 05/11/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Gastroenterology | ||||||
| 06/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/26/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $88.48 | General |
| Category: HCV | ||||||
| 04/14/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Gastroenterology | ||||||
| 04/14/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Gastroenterology | ||||||
| 12/19/2019 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: HCV | ||||||
| 12/04/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Travel and Lodging | Cash or cash equivalent | $303.03 | General |
| Category: THERAPIES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,190 | 1,269 | $998,584 | $114,210 |
| 2022 | 14 | 876 | 922 | $704,034 | $87,907 |
| 2021 | 6 | 179 | 183 | $120,738 | $19,406 |
Total Patients
2,245
Total Services
2,374
Medicare Billing
$221,523
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 157 | 157 | $273,965 | $30,818 | 11.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 217 | 219 | $382,155 | $16,239 | 4.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 221 | $18,197 | $10,986 | 60.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 137 | $16,440 | $10,716 | 65.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 154 | 160 | $143,200 | $10,626 | 7.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 147 | 147 | $18,378 | $7,923 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $14,680 | $7,501 | 51.1% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 14 | 14 | $26,810 | $3,681 | 13.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 20 | 20 | $21,840 | $3,332 | 15.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 26 | $4,472 | $2,918 | 65.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $9,612 | $2,460 | 25.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $19,656 | $2,396 | 12.2% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 16 | 16 | $10,512 | $2,255 | 21.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 16 | 17 | $25,959 | $1,375 | 5.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 13 | $1,807 | $836.42 | 46.3% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $10,901 | $146.48 | 1.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 105 | 108 | $188,460 | $19,936 | 10.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 146 | 148 | $261,750 | $11,721 | 4.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 107 | 107 | $20,758 | $9,487 | 45.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 136 | 136 | $16,728 | $7,963 | 47.6% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2022 | 21 | 24 | $45,960 | $6,513 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 86 | $10,419 | $6,115 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 115 | $9,505 | $5,864 | 61.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 29 | 29 | $31,668 | $5,257 | 16.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 83 | 84 | $75,180 | $4,924 | 6.5% |
About Dr. Majd Michael, M.D
Dr. Majd Michael, M.D is a Gastroenterology healthcare provider based in Cameron Park, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1306223177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Majd Michael, M.D has received a total of $2,155 in payments from pharmaceutical and medical device companies, with $145.41 received in 2024. These payments were reported across 44 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,702).
As a Medicare-enrolled provider, Michael has provided services to 2,245 Medicare beneficiaries, totaling 2,374 services with total Medicare billing of $221,523. Data is available for 3 years (2021–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Cameron Park, CA
- Active Since 04/30/2015
- Last Updated 08/26/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306223177
Products in Payments
- GENERAL THERAPIES (Device) $374.68
- Epclusa (Drug) $338.47
- XELJANZ (Drug) $274.72
- Trulance (Drug) $197.50
- DUPIXENT (Biological) $155.08
- GATTEX (Drug) $150.00
- OCALIVA (Drug) $121.14
- ENTYVIO (Biological) $90.54
- WALLFLEX (Device) $86.83
- XIFAXAN (Drug) $65.10
- EVIS EXERA (Device) $46.88
- ELIQUIS (Drug) $37.47
- STELARA (Biological) $35.62
- HADLIMA (Drug) $30.51
- CHANTIX (Drug) $29.50
- SUFLAVE (Drug) $27.97
- ZEJULA (Drug) $22.95
- DALVANCE (Drug) $18.09
- SUTAB (Drug) $17.88
- BRIDION (Drug) $16.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Cameron Park
Matthew Cole, M.d., M.p.h, M.D., M.P.H
Gastroenterology — Payments: $1,537
Gastroenterology $1,537
Dr. Christopher Romberg, Md, MD
Gastroenterology — Payments: $1,499
Gastroenterology $1,499
Dr. Wai Kan Chiu, M.d., Ph.d, M.D., PH.D
Gastroenterology — Payments: $808.87
Gastroenterology $808.87
Russell Jacoby, Md, MD
Gastroenterology — Payments: $132.02
Gastroenterology $132.02